Chonluten peptide is a synthetic bioregulator primarily developed to support lung and respiratory health, with emerging research suggesting benefits for cartilage, gastrointestinal tissue, and overall cellular repair. 
Lung and Respiratory Health
Promotes lung tissue repair and regeneration by modulating gene expression related to epithelial cell renewal and collagen synthesis. 
Reduces inflammation in the lungs by regulating cytokines (e.g., IL-6, TNF, IL-17) and immune signaling pathways (STAT1/STAT3), which may help manage chronic conditions like asthma, COPD, bronchitis, and post-viral respiratory issues. 
Improves lung function and oxygen exchange, enhancing respiratory capacity and endurance—beneficial for athletes and individuals recovering from respiratory illness. 
Supports age-related respiratory decline by maintaining lung tissue integrity and slowing functional deterioration. 
Cartilage and Joint Health
Stimulates chondrocyte proliferation and extracellular matrix synthesis, supporting cartilage regeneration and joint stability. 
Reduces joint pain and stiffness, particularly in conditions like osteoarthritis and sports-related injuries, by promoting healthy collagen production and reducing inflammation. 
Enhances mobility and flexibility, helping to maintain active lifestyles and potentially slowing joint aging. 
Gastrointestinal and Cellular Protection
Supports repair of the stomach lining by reducing apoptosis (cell death) and potentially regulating heat shock protein 70 (HSP70), which protects cells from stress-induced damage. 
Acts as a gene expression modulator, influencing DNA methylation and histone interactions, which may contribute to anti-aging (geroprotective) effects at the cellular level. 
Safety and Use
Well-tolerated in studies with no reported side effects, but medical supervision is recommended, especially for individuals with chronic conditions or those on medication. 
Typically used in 10–30 day cycles, with dosages ranging from 10–20 mg/day, depending on the condition and formulation.
Note: While preclinical and early clinical data are promising, large-scale human trials are limited, and Chonluten is not approved by the FDA for medical use.  It is intended for research and wellness applications only.